Andrew C W Zannettino
Overview
Explore the profile of Andrew C W Zannettino including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
143
Citations
3829
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kumorkiewicz-Jamro A, Pachulicz R, Fitter S, Gorska R, Duggan J, Vandyke K, et al.
Food Chem
. 2024 Aug;
462:140920.
PMID: 39208732
The use of direct injection ion mobility mass spectrometry (DI-IM-MS) to detect and identify betacyanin pigments in A. hortensis 'rubra' extracts was explored for the first time, with results compared...
2.
Lill C, Fitter S, Zannettino A, Vandyke K, Noll J
Cancer Metastasis Rev
. 2024 Aug;
43(4):1385-1399.
PMID: 39102101
Paediatric patients with relapsed B cell acute lymphoblastic leukaemia (B-ALL) have poor prognosis, as relapse-causing clones are often refractory to common chemotherapeutics. While the molecular mechanisms leading to chemoresistance are...
3.
Zeissig M, Hewett D, Mrozik K, Panagopoulos V, Wallington-Gates C, Spencer A, et al.
Leuk Res
. 2024 Mar;
139:107469.
PMID: 38479337
Background: The proteasome inhibitor bortezomib is one of the primary therapies used for the haematological malignancy multiple myeloma (MM). However, intrinsic or acquired resistance to bortezomib, via mechanisms that are...
4.
Wardill H, Wooley L, Bellas O, Cao K, Cross C, van Dyk M, et al.
Br J Cancer
. 2023 Oct;
130(1):19-30.
PMID: 37884682
The side effects of cancer therapy continue to cause significant health and cost burden to the patient, their friends and family, and governments. A major barrier in the way in...
5.
Davies M, Greenberg Z, van Vuurden D, Cross C, Zannettino A, Bardy C, et al.
Brain Behav Immun
. 2023 Oct;
115:229-247.
PMID: 37858741
Childhood is recognised as a period of immense physical and emotional development, and this, in part, is driven by underlying neurophysiological transformations. These neurodevelopmental processes are unique to the paediatric...
6.
Williams C, Noll J, Bradey A, Duggan J, Wilczek V, Masavuli M, et al.
Br J Haematol
. 2023 Sep;
203(4):614-624.
PMID: 37699574
Expression of myeloperoxidase (MPO), a key inflammatory enzyme restricted to myeloid cells, is negatively associated with the development of solid tumours. Activated myeloid cell populations are increased in multiple myeloma...
7.
Plakhova N, Panagopoulos V, Vandyke K, Zannettino A, Mrozik K
Cancer Metastasis Rev
. 2023 Jan;
42(1):277-296.
PMID: 36622509
Acute myeloid leukaemia (AML), chronic lymphocytic leukaemia (CLL), and multiple myeloma (MM) are age-related haematological malignancies with defined precursor states termed myelodysplastic syndrome (MDS), monoclonal B-cell lymphocytosis (MBL), and monoclonal...
8.
Kaul L, Grundmann C, Koll-Weber M, Loffler H, Weiz A, Zannettino A, et al.
Pharmaceutics
. 2022 Dec;
14(12).
PMID: 36559332
Prophylaxis and the treatment of surgical site infections (SSIs) with antibiotics frequently fail due to the antibiotic resistance of bacteria and the ability of bacteria to reside in biofilms (i.e.,...
9.
Kaul L, Abdo A, Coenye T, Krom B, Hoogenkamp M, Zannettino A, et al.
Front Microbiol
. 2022 Sep;
13:999893.
PMID: 36160243
and are associated with life-threatening infections. Despite the best medical care, these infections frequently occur due to antibiotic resistance and the formation of biofilms of these two bacteria (i.e., clusters...
10.
Bradey A, Fitter S, Duggan J, Wilczek V, Williams C, Cheney E, et al.
Sci Rep
. 2022 Jul;
12(1):13128.
PMID: 35908046
Multiple myeloma (MM) is an incurable haematological malignancy, caused by the uncontrolled proliferation of plasma cells within the bone marrow (BM). Obesity is a known risk factor for MM, however,...